These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18055171)

  • 21. Effect of route of EPO administration on hemodialysis arteriovenous vascular access failure: a randomized controlled trial.
    Lee YK; Koo JR; Kim JK; Park II; Joo MH; Yoon JW; Noh JW; Vaziri ND
    Am J Kidney Dis; 2009 May; 53(5):815-22. PubMed ID: 19324483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement.
    Yevzlin AS; Sanchez RJ; Hiatt JG; Washington MH; Wakeen M; Hofmann RM; Becker YT
    Semin Dial; 2007; 20(4):351-4. PubMed ID: 17635828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-emptive angioaccess for haemodialysis in the elderly.
    Morsy M; Betal D; Nelson S; Malete H; Whitmore A; Chemla E
    Nephrol Dial Transplant; 2011 Nov; 26(11):3666-70. PubMed ID: 21421596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin-bonded expanded polytetrafluorethylene grafts in hemodialysis access.
    Olsha O; Goldin I; Shemesh D
    J Vasc Access; 2016 Mar; 17 Suppl 1():S79-84. PubMed ID: 26951912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin bonded hemodialysis e-PTFE grafts result in 20% clot free survival benefit.
    Davidson I; Hackerman C; Kapadia A; Minhajuddib A
    J Vasc Access; 2009; 10(3):153-6. PubMed ID: 19670166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of hand ischemia by arterial ligation and upper extremity bypass after angioaccess surgery.
    Katz S; Kohl RD
    J Am Coll Surg; 1996 Sep; 183(3):239-42. PubMed ID: 8784317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of frequency of complications of arterio venous fistula in patients on dialysis: a two-year single center study from Iran.
    Derakhshanfar A; Gholyaf M; Niayesh A; Bahiraii S
    Saudi J Kidney Dis Transpl; 2009 Sep; 20(5):872-5. PubMed ID: 19736495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Access thrombosis, hospitalization, and hematocrit level in hemodialysis patients.
    Heard KA; Russell TA
    Nephrol Nurs J; 2000 Dec; 27(6):607-11. PubMed ID: 16649341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Seminars in Vascular Surgery. Contemporary issues in hemodialysis access. Introduction.
    Huber TS; Cull DL
    Semin Vasc Surg; 2011 Jun; 24(2):61-2. PubMed ID: 21889092
    [No Abstract]   [Full Text] [Related]  

  • 30. Some old drugs improve late primary patency rate of native arteriovenous fistulas in hemodialysis patients.
    Righetti M; Ferrario G; Serbelloni P; Milani S; Tommasi A
    Ann Vasc Surg; 2009; 23(4):491-7. PubMed ID: 18973987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of evidence for use of heparin-bonded grafts in access surgery: a meta-analysis.
    Lazarides MK; Argyriou C; Antoniou GA; Georgakarakos E; Georgiadis GS
    Semin Vasc Surg; 2016 Dec; 29(4):192-197. PubMed ID: 28779786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The patency rate and complications of polytetrafluoroethylene vascular access grafts in hemodialysis patients: a prospective study from Iran.
    Salimi J; Zafarghandi MR
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):280-5. PubMed ID: 18310884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periprocedural Outcomes in Patients on Chronic Anticoagulation Undergoing Fistulograms.
    Paredes LG; Arinze NV; Farber A; Garofalo D; Cheng TW; Levin SR; Vilvendhan R; Siracuse JJ
    Ann Vasc Surg; 2021 Jan; 70():123-130. PubMed ID: 32416311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclavian vein to right atrial appendage bypass without sternotomy to maintain arteriovenous access in patients with complete central vein occlusion, a new approach.
    Glass C; Maevsky V; Massey T; Illig K
    Ann Vasc Surg; 2009; 23(4):465-8. PubMed ID: 19359137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage.
    Yang JW; Han BG; Kim BR; Lee YH; Kim YS; Yu JM; Choi SO
    Ren Fail; 2009; 31(8):668-75. PubMed ID: 19814633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ligation of the distal vein in snuff-box arteriovenous fistula.
    Beigi AA; Masoudpour H; Alavi M
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1110-4. PubMed ID: 19861886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation.
    Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S
    Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients.
    Sharathkumar A; Hirschl R; Pipe S; Crandell C; Adams B; Lin JJ
    J Vasc Access; 2007; 8(4):235-44. PubMed ID: 18161668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful angioaccess.
    Singh N; Starnes BW; Andersen C
    Surg Clin North Am; 2007 Oct; 87(5):1213-28, xi. PubMed ID: 17936483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
    Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
    Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.